Together with the fact that Miro1 physically and functionally interacts with a number of PD-related proteins, Miro1 has recently been proposed both as a molecular signature in PD and as a therapeutic target, which could be used as a biomarker for the diagnosis and treatment of PD (66). This evidence concerns the gene RHOT1 and Parkinson disease.